Biotage Launches TurboVap[®] 96 Dual Evaporator

Uppsala, 25th January 2022, Biotage is pleased to announce the launch of a sophisticated well plate evaporator, the TurboVap® 96 Dual – a second-generation system with two separate, and independently controlled evaporation compartments, building upon the reputable foundation of the Biotage TurboVap® product line.

The new TurboVap® 96 Dual has been designed to support enhanced well-plate evaporation within the sample preparation workflow. With its unique two in one functionality users can run the same method on two plates simultaneously, or two independent evaporations, essentially doubling throughput. The capability to act as two single units and a dual, enabling laboratories an opportunity to balance their evolving sample throughput needs.

TurboVap® 96 Dual is dedicated to the evaporation of solvents in 24, 48, or 96 well plate array formats the new system can evaporate solvent levels from microliters up to 10 mL per well. The system applies user controlled heated nitrogen from the top, while simultaneously heating the bottom of the well plate by convection. Evaporated solvent vapors are contained and evacuated under negative pressure.

TurboVap® 96 Dual monitors both energy and gas consumption for each evaporation cabinet, so laboratories can accurately manage and forecast their future requirements. The systems small footprint easily fits inside a standard chemical fume hoods and the integral touchscreen further reduces its footprint when compared to the classic TurboVap® systems.

“The introduction of the new TurboVap® 96 Dual reinvents evaporation, placing the customer in full control of an intelligent and smart evaporation system. Proof positive of our commitment to HumanKind Unlimited, making the world healthier, greener and cleaner” said Tomas Blomquist, CEO Biotage.

#####

For further press information from Biotage, please contact: James Churchill, Marketing Communications Manager - International, Biotage GB Ltd. Distribution Way, Dyffryn Business Park, Ystrad Mynach, CF82 7TS United Kingdom. Tel: +44 (0)1443 811 849. Mobile: +44 (0) 7875 484778. Email: james.churchill@biotage.com
 

About Biotage

Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in Drug Discovery and Development, Analytical Testing and Water and Environmental Testing. Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited. Our customers span a broad range of market segments including Pharmaceutical, Biotech, Contract Research and Contract Manufacturers as well as Clinical, Forensic and Academic laboratories in addition to organizations focused on Food safety, Clean water and Environmental sustainability. Biotage is headquartered in Uppsala in Sweden and employs approx. 485 people worldwide. The Group had sales of SEK 1,092 million in 2020 and our products are sold in more than 70 countries. Biotage share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.